Abstract
With the detection of a homozygous deletion of the survival motor neuron 1 gene (SMN1), prenatal and preimplantation genetic diagnosis (PGD) for spinal muscular atrophy has become feasible and widely applied. The finding of a de novo rearrangement, resulting in the loss of the SMN1 gene, reduces the recurrence risk from 25% to a lower percentage, the residual risk arising from recurrent de novo mutation or germline mosaicism. In a couple referred to our PGD center because their first child was affected with SMA, the male partner was shown to carry two SMN1 copies. An analysis of the SMN1 gene and two flanking markers was performed on 12 single spermatozoa, to determine whether the father carried a CIS duplication of the SMN1 gene on one chromosome and was a carrier, or if the deletion has occurred de novo. We showed that all spermatozoa that were carriers of the ‘at-risk haplotype’ were deleted for the SMN1 gene, confirming the carrier status of the father. We provide an original application of single germ cell studies to recessive disorders using coamplification of the gene and its linked markers. This efficient and easy procedure might be useful to elucidate complex genetic situations when samples from other family members are not available.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ogino S, Wilson RB : Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum Genet 2002; 111: 477–500.
Pearn J : Classification of spinal muscular atrophies. Lancet 1980; 1: 919–922.
Munsat TL : International SMA collaboration. Neuromuscular Disord 1991; 1: 81.
Melki J, Abdelhak S, Sheth P et al: Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 1990; 344: 767–768.
Brzustowicz LM, Lehner T, Castilla LH et al: Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 1990; 344: 540–541.
Gilliam TC, Brzustowicz LM, Castilla LH et al: Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 1990; 345: 823–825.
Melki J, Sheth P, Abdelhak S et al: Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12- q14. Lancet 1990; 336: 271–273.
Melki J, Lefebvre S, Burglen L et al: De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 1994; 264: 1474–1477.
Lefebvre S, Burlet P, Liu Q et al: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997; 16: 265–269.
Feldkötter M, Schwarzer V, Wirth R et al: Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358–368.
Bürglen L, Lefebvre S, Clermont O et al: Structure and organization of the human survival motor neurone (SMN) gene. Genomics 1996; 32: 479–482.
van der Steege G, Grootscholten PM, van der Vlies P et al: PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995; 345: 985–986.
Lefebvre S, Bürglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy determining gene. Cell 1995; 80: 155–165.
McAndrew PE, Parsons DW, Simard LR et al: Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997; 60: 1411–1422.
Wirth B, Herz M, Wetter A et al: Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 1999; 64: 1340–1356.
Saugier-Veber P, Drouot N, Lefebvre S et al: Detection of heterozygous SMN1 deletions in SMA families using a simple fluorescent multiplex PCR method. J Med Genet 2001; 38: 240–243.
Chen KL, Wang YL, Rennert H et al: Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy. Am J Med Genet 1999; 85: 463–469.
Ogino S, Wilson RB : SMN dosage analysis and risk assessment for spinal muscular atrophy. Am J Hum Genet 2002; 70: 1596–1598.
Dib C, Fauré S, Fizames C et al: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996; 380: 152–154.
Gyapay G, Morissette J, Vignal A et al: The 1993–94 Généthon human genetic linkage map. Nat Genet 1994; 7: 246–339.
Wirth B, Schmidt T, Hahnen E et al: De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet 1997; 61: 1102–1111.
Zeesman S, Whelan DT, Carson N et al: Parents of children with spinal muscular atrophy are not obligate carriers: carrier testing is important for reproductive decision-making. Am J Med Genet 2002; 107: 247–249.
Cui XF, Li HH, Goradia TM et al: Single-sperm typing: determination of genetic distance between the G gamma-globin and parathyroid hormone loci by using the polymerase chain reaction and allele-specific oligomers. Proc Natl Acad Sci USA 1989; 86: 9389–9393.
Burlet P, Frydman N, Gigarel N et al: Improved single-cell protocol for preimplantation genetic diagnosis of spinal muscular atrophy. Fertil Steril 2005; 84: 734–739.
Yaron Y, Cohen T, Mey-Raz N et al: Detection of spinal muscular atrophy carriers by nested polymerase chain reaction of single sperm cells. Genet Test 2006; 10: 18–23.
Altarescu G, Brooks B, Kaplan Y et al: Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. Hum Reprod 2006; 21: 2047–2051.
Verlinsky Y, Rechitsky S, Schoolcraft W et al: Preimplantation diagnosis for homeobox gene HLXB9 mutation causing Currarino syndrome. Am J Med Genet A 2005; 134: 103–104.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Burlet, P., Gigarel, N., Magen, M. et al. Single-sperm analysis for recurrence risk assessment of spinal muscular atrophy. Eur J Hum Genet 18, 505–508 (2010). https://doi.org/10.1038/ejhg.2009.198
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2009.198
Keywords
This article is cited by
-
Präimplantationsdiagnostik – methodische Aspekte
Medizinische Genetik (2016)
